Abstract
Suppression of the host innate immune response is a critical aspect of viral replication. Upon infection, viruses may introduce one or more proteins that inhibit key immune pathways, such as the type I interferon pathway. However, the ability to predict and evaluate viral protein bioactivity on targeted pathways remains challenging and is typically done on a single virus/gene basis. Here, we present a medium-throughput high-content cell-based assay to reveal the immunosuppressive effects of viral proteins. To test the predictive power of our approach, we developed a library of 800 genes encoding known, predicted, and uncharacterized human viral genes. We find that previously known immune suppressors from numerous viral families such as Picornaviridae and Flaviviridae recorded positive responses. These include a number of viral proteases for which we further confirmed that innate immune suppression depends on protease activity. A class of predicted inhibitors encoded by Rhabdoviridae viruses was demonstrated to block nuclear transport, and several previously uncharacterized proteins from uncultivated viruses were shown to inhibit nuclear transport of the transcription factors NF-κB and IRF3. We propose that this pathway-based assay, together with early sequencing, gene synthesis, and viral infection studies, could partly serve as the basis for rapid in vitro characterization of novel viral proteins.
Introduction
When a virus infects a cell, the host’s innate immune system acts like a burglar alarm, triggering pathways such as the Type I Interferon response to halt viral replication and alert neighboring cells. To survive, viruses have evolved "immunosuppressive" proteins that disrupt these signaling pathways. While metagenomic sequencing is uncovering new viruses at an unprecedented rate, functional characterization of their proteins remains a significant bottleneck. Traditional "one-gene-at-a-time" research is too slow to keep up with emerging threats. There is a critical need for standardized, scalable assays that can rapidly link viral sequences to their immunosuppressive functions.
Methods
We developed a multipronged discovery pipeline combining bioinformatic prediction with high-content imaging.
Bioinformatic Library Construction
We curated a library of 800 viral genes using sequence similarity and domain analysis (Pfam). This library included 605 genes from 31 viral families and 195 genes from Coronaviridae. The collection encompassed known inhibitors (controls), predicted inhibitors, and 536 sequences with previously unannotated functions.
High-Content Screening (HCS) Assay
We utilized BJ-5ta human fibroblasts as a model system. To reduce background noise from transfected DNA, we used CRISPR to knock out the cGAS gene. This "silenced" the internal DNA-sensing machinery, allowing us to isolate the effects of viral proteins on specific external stimuli, such as cGAMP (STING pathway), poly(I:C) (RLR pathway), or IFNα (JAK-STAT pathway).
Automated fluorescence microscopy was used to track the movement of key transcription factors (IRF3, NF-κB, and pSTAT1). In a normal immune response, these proteins translocate from the cytoplasm to the nucleus. Viral inhibitors are identified by their ability to trap these factors in the cytoplasm.
Results
The screen identified 79 stringent hits (p < 0.05) that significantly inhibited transcription factor translocation.
- Pathway Specificity: Most viral proteins were specialists, often inhibiting IRF3 (the primary viral alarm) but not NF-κB (the general inflammatory alarm).
- Validation of SARS-CoV-2: The assay identified Orf6 as a potent inhibitor of pSTAT1 and Nsp1 as a broad suppressor, validating the HCS approach against known high-profile pathogens.
- Unmasking Understudied Viruses: We identified a novel immune suppressor in Torque Teno Virus (TTV), a common but poorly understood virus. We also found that Matrix (M) proteins from the Rhabdoviridae family act as "gatekeepers," physically blocking nuclear pores.
- Protease Moonlighting: We confirmed that several viral proteases, such as the 3C protease from Salivirus A, inhibit IRF3 translocation through their proteolytic activity.
Discussion
By creating a "clean" experimental environment through cGAS knockout, we successfully developed a robust platform for identifying specific viral antagonists. This study demonstrates that high-content screening can rapidly characterize the "arsenal" of a virus, providing functional insights that complement genomic sequencing. While the study of isolated proteins in a single cell type has limitations—such as missing protein complex interactions or tissue-specific responses—this platform represents a practical step toward the early-stage evaluation of emerging and understudied viruses. Future work could deploy this tool as a "first response" mechanism during outbreaks, characterizing new viral proteins within weeks of genome sequencing.
Summary updated